zur Navigation zum Inhalt


Milestones in advanced renal cell carcinoma

03/2017 Renal cell carcinoma (RCC) is a common tumor that is largely refractory to cytotoxic agents. With the implementation of a multitude of novel therapies in the past 10 years, the overall survival of patients with advanced RCC has more than doubled. [...]

Breast cancer milestones 2007–2016

03/2017 Over the past 10 years, enormous progress has been made in breast cancer (BC) treatment, leading to a substantial decline in BC mortality in Western countries. Although the following short review is necessarily incomplete, the discussion will highlight major achievements in the field. [...]

Milestones in Chronic Lymphocytic Leukemia

03/2017 An exciting decade of progress—10th anniversary of memo The past 10 years have been an exciting ride for Chronic Lymphocytic Leukemia (CLL) aficionados. An overview of changes in management paradigms in CLL, ranging from insights into biology, via chemotherapy and chemoimmunotherapy to maintenance and novel drugs will be presented. [...]

To print or not to print

03/2017 Or the publisher’s dilemma how to present a growing complexity of scientific knowledge to clinicians, helping them to improve their daily care for their patients

Ten years ago, in spring 2007 a noble lady wearing a queenly looking hat invited me (WH) to start a new printed journal on hematology and oncology with a focus on the German-speaking community. [...]

memo: Official journal of the OeGHO and CECOG

03/2017 As Vice-President of the Austrian Society of Hematology and Medical Oncology, I have the pleasure and honor to congratulate _memo_ on its 10-year anniversary. This international journal for oncology and hematology professionals now has an established role in the landscape of clinical hematology and oncology print media. [...]

memo: Spectacular developments during the last decade from the Section Editors’ point of view

03/2017 Spectacular developments in neuro-oncology during the last decade

_Silvia Hofer,_ _Switzerland_

The 2016 World Health Organization Classification of Tumors of the Central Nervous System introduced for the first time molecular parameters in addition to histology to define tumor entities. [...]

Medizin heute

Aktuelle Printausgaben